Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
Objectives: The study aimed to compare the immunogenicity and safety of fractional (half) third doses of heterologous COVID-19 vaccines (AZD1222 or BNT162b2) to full doses after the two-dose CoronaVac and when boosting after three different extended intervals. Methods: At 60-<90, 90-<120, or 1...
Saved in:
Main Author: | Niyomnaitham S. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82095 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination
by: Suntronwong N.
Published: (2023) -
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac<sup>®</sup>, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
by: Chatsiricharoenkul S.
Published: (2023) -
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination
by: Assawakosri S.
Published: (2023) -
Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
by: Niyomnaitham S.
Published: (2023) -
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
by: Goh, Yun Shan, et al.
Published: (2022)